Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Feasibility trial of desmopressin before procedures in critically ill thrombocytopenic adults
2016-001126-33Phase 2Completed
- Sponsor
- NHS Blood and Transplant
- Start
- Sep 2016
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of octreotide in Thrombocytopenia (2 arms), sponsored by NHS Blood and Transplant. Primary endpoint: Primary feasibility outcome. Started Sep 2016; status: completed.
02
Drugs
octreotide
03
Conditions
Thrombocytopenia
Beyond the preview
Go deeper on 2016-001126-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-001126-33.